Protein inheritance (prions) based on parallel in-register β-sheet amyloid structures

BioEssays

Volumn 30, Issue 10, 2008, Pages 955-964

  Wickner, Reed B ^a   Shewmaker, Frank ^a   Kryndushkin, Dmitry ^a   Edskes, Herman K ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; CHAPERONE; PRION PROTEIN; AMYLOID; SACCHAROMYCES CEREVISIAE PROTEIN; SUP35 PROTEIN, S CEREVISIAE; URE2 PROTEIN, S CEREVISIAE;

AMINO ACID SEQUENCE; BETA SHEET; CRYSTAL STRUCTURE; ENZYME ACTIVATION; FUNGUS TRANSMISSION; HETEROKARYON; NITROGEN METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOSPORA ANSERINA; PRION DISEASE; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SACCHAROMYCES CEREVISIAE; CHEMISTRY; GENETICS; PODOSPORA; PRION; PROTEIN SECONDARY STRUCTURE; ULTRASTRUCTURE;

MAMMALIA; PODOSPORA ANSERINA; SACCHAROMYCES CEREVISIAE;

AMYLOID; PODOSPORA; PRIONS; PROTEIN STRUCTURE, SECONDARY; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 53149116688     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20821     Document Type: Review

References (111)

1. Griffith JS. 1967. Self-replication and scrapie. Nature 215:1043-1044.
2. Alper T, Cramp WA, Haig DA, Clarke MC. 1967. Does the agent of scrapie replicate without nucleic acid? Nature 214:764-766.
3. Bolton DC, McKinley MP, Prusiner SB. 1982. Identification of a protein that purifies with the scrapie prion. Science 218:1309-1311.
4. Dickinson AG, Meikle VMH, Fraser H. 1968. Identification of a gene which controls the incubation period of some strains of scrapie in mice. J Comp Path 78:293-299.
5. Carlson GA, Goodman PA, Lovett M, Taylor BA, Marshall ST, et al. 1988. Genetics and polymorphism of the mouse prion gene complex: control of scrapie incubation time. Mol Cell Biol 8:5528-5540.
6. Bueler H, Aguzzi A, Sailer A, Greiner R-A, Autenried P, et al. 1993. Mice devoid of PrP are resistant to Scrapie. Cell 73:1339-1347.
7. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, et al. 1994. Cell-free formation of protease-resistant prion protein. Nature 370:471-474.
8. Legname G, Baskakov IV, Nguyen H-OB, Reisner D, Cohen FE, et al. 2004. Synthetic mammalian prions. Science 305:673-676.
9. Castilla J, Saa P, Hetz C, Soto C. 2005. In vitro generation of infectious scrapie prions. Cell 121:195-206.
10. Deleault NR, Harris BT, Rees JR, Supattapone S. 2007. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104:9741-9746.
11. Cox BS. 1965. PSI, a cytoplasmic suppressor of super-suppressor in yeast. Heredity 20:505-521.
12. Cox BS, Tuite MF, McLaughlin CS. 1988. The Psi factor of yeast: a problem in inheritance. Yeast 4:159-179.
13. Lacroute F. 1971. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J Bacteriol 106:519-522.
14. Aigle M, Lacroute F. 1975. Genetical aspects of [URE3], a non-Mendelian, cytoplasmically inherited mutation in yeast. Molec Gen Genet 136:327-335.
15. Wickner RB. 1994. [URE3] as an altered URE2 protein: evidence for a prion analog in S. cerevisiae. Science 264:566-569.
16. Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW. 1997. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147:507-519.
17. Derkatch IL, Bradley ME, Hong JY, Liebman SW. 2001. Prions affect the appearance of other prions: the story of [PIN]. Cell 106:171-182.
18. Sondheimer N, Lindquist S. 2000. Rnq1: an epigenetic modifier of protein function in yeast. Molec Cell 5:163-172.
19. Du Z, Park K-W, Yu H, Fan Q, Li L. 2008. Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nat Genet 40:460-465.
20. Cooper TG. 2002. Transmitting the signal of excess nitrogen in Saccharomyces cerevisiae from the Tor proteins to th GATA factors: connecting the dots. FEMS Microbiol Revs 26:223-238.
21. Drillien R, Lacroute F. 1972. Ureidosuccinic acid uptake in yeast and some aspects of its regulation. J Bacteriol 109:203-208.
22. Turoscy V, Cooper TG. 1987. Ureidosuccinate is transported by the allantoate transport system in Saccharomyces cerevisiae. J Bacteriol 169:2598-2600.
23. Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, et al. 1995. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14:4365-4373.
24. Zhouravleva G, Frolova L, LeGoff X, LeGuellec R, Inge-Vectomov S, et al. 1995. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 14:4065-4072.
25. Saupe SJ. 2000. Molecular genetics of heterokaryon incompatibility in filamentous ascomycetes. Microbiol Mol Biol Revs 64:489-502.
26. Rizet G. 1952. Les phenomenes de barrage chez Podospora anserina: analyse genetique des barrages entre les souches s et S Rev. Cytol Biol Veg 13:51-92.
27. Coustou V, Deleu C, Saupe S, Begueret J. 1997. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 94:9773-9778.
28. Roberts BT, Wickner RB. 2003. A class of prions that propagate via covalent auto-activation. Genes Dev 17:2083-2087.
29. Jones EW. 1991. Three proteolytic systems in the yeast Saccharomyces cerevisiae. J Biol Chem 266:7963-7966.
30. Zubenko GS, Park FJ, Jones EW. 1982. Genetic properties of mutations at the PEP4 locus in Saccharomyces cerevisiae. Genetics 102:679-690.
31. Kicka S, Bonnet C, Sobering AK, Ganesan LP, Silar P. 2006. A mitotically inheritable unit containing a MAP kinase module. Proc Natl Acad Sci USA 103:13445-13450.
32. Masison DC, Wickner RB. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270:93-95.
33. Masison DC, Maddelein M-L, Wickner RB. 1997. The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. Proc Natl Acad Sci USA 94:12503-12508.
34. Taylor KL, Cheng N, Williams RW, Steven AC, Wickner RB. 1999. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science 283:1339-1343.
35. Baxa U, Taylor KL, Wall JS, Simon MN, Cheng N, et al. 2003. Architecture of Ure2p prion filaments: the N-terminal domain forms a central core fiber. J Biol Chem 278:43717-43727.
36. Brachmann A, Baxa U, Wickner RB. 2005. Prion generation in vitro: amyloid of Ure2p is infectious. Embo J 24:3082-3092.
37. TerAvanesyan A, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN. 1994. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137:671-676.
38. King C-Y, Tittmann P, Gross H, Gebert R, Aebi M, et al. 1997. Prion-inducing domain2-114of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 94:6618-6622.
39. King CY, Diaz-Avalos R. 2004. Protein-only transmission of three yeast prion strains. Nature 428:319-323.
40. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. 2004. Conformational variations in an infectious protein determine prion strain differences. Nature 428:323-328.
41. Pierce MM, Baxa U, Steven AC, Bax A, Wickner RB. 2005. Is the prion domain of soluble Ure2p unstructured? Biochemistry 44:321-328.
42. Baxa U, Wickner RB, Steven AC, Anderson D, Marekov L, et al. 2007. Characterization of β-sheet structure in Ure2p1-89yeast prion fibrils by solid state nuclear magnetic resonance. Biochemistry 46:13149-13162.
43. +] prion by fragments of Rnq1 fused to GFP. Curr Genet 51:309-319.
44. Patel BK, Liebman SW. 2007. "Prion proof" for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]. J Mol Biol 365:773-782.
45. Balguerie A, Dos Reis S, Ritter C, Chaignepain S, Coulary-Salin B, et al. 2003. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. Embo J 22:2071-2081.
46. Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. 2002. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci USA 99:7402-7407.
47. Wickner RB. 1997. A new prion controls fungal cell fusion incompatibility. Proc Natl Acad Sci USA 94:10012-10014.
48. True HL, Lindquist SL. 2000. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407:477-483.
49. Harrison LB, Yu Z, Stajich JE, Dietrich FS, Harrison PM. 2007. Evolution of budding yeast prion-determinant sequences across diverse fungi. J Mol Biol. doi:10.1016/j.jmb.2007.01.070.
50. Shewmaker F, Mull L, Nakayashiki T, Masison DC, Wickner RB. 2007. Ure2p function is enhanced by its prion domain in Saccharomyces cerevisiae. Genetics 176:1557-1565.
51. Urakov VN, Valouev IA, Kochneva-Pervukhova NV, Pakeiser AN, Vishnevsky AY, et al. 2006. N-terminal region of Saccharomyces cerevisiae eRF3 is essential for the functioning of the eRF1/eRF3 complex beyond translation termination. BMC Mol Biol 7:34-46.
52. Talarek N, Maillet L, Cullin C, Aigle M. 2005. The [URE3] prion is not conserved among Saccharomyces species. Genetics 171:23-54.
53. Nakayashiki T, Kurtzman CP, Edskes HK, Wickner RB. 2005. Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci USA 102: 10575-10580.
54. Edskes HK, Wickner RB. 2002. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full - length protein. Proc Natl Acad Sci USA 99:16384-16391.
55. Palmer MS, Dryden AJ, Hughes JT, Collinge J. 1991. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352:340-342.
56. Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, et al. 2003. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300:640-643.
57. Chen B, Newnam GP, Chernoff YO. 2007. Prion species barrier between the closely related yeast proteins is detected despite coaggregation. Proc Natl Acad Sci USA 104:2791-2796.
58. Dalstra HJP, Swart K, Debets AJM, Saupe SJ, Hoekstra RF. 2003. Sexual transmission of the [Het-s] prion leads to meiotic drive in Podospora anserina. Proc Natl Acad Sci USA 100:6616-6621.
59. Wilson PG, Culbertson MR. 1988. SUF12 suppressor protein of yeast: a fusion protein related to the EF-1 family of elongation factors. J Mol Biol 199:559-573.
60. Ross ED, Baxa U, Wickner RB. 2004. Scrambled prion domains form prions and amyloid. Mol Cell Biol 24:7206-7213.
61. Ross ED, Edskes HK, Terry MJ, Wickner RB. 2005. Primary sequence independence for prion formation. Proc Natl Acad Sci USA 102:12825-12830.
62. Priola SA, Caughey B, Race RE, Chesebro B. 1994. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68:4873-4878.
63. - mutation which eliminates the [PSI] factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137:659-670.
64. DePace AH, Santoso A, Hillner P, Weissman JS. 1998. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93:1241-1252.
65. Ross ED, Minton AP, Wickner RB. 2005. Prion domains: sequences, structures and interactions. Nat. Cell Biol 7:1039-1044.
66. Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, et al. 2005. Structure of the cross-β spine of amyloid-like fibrils. Nature 435:773-778.
67. Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, et al. 2007. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 447:453-457.
68. Jaroniec CP, MacPhee CE, Bajaj VS, McMahon MT, Dobson CM, et al. 2004. High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopy. Proc Natl Acad Sci USA 101:711-716.
69. Spencer RGS, Halverson KJ, Auger M, McDermott AE, Griffin RG, et al. 1991. An unusual peptide conformation may precipitate amyloid formation in Alzheimer's disease: application of solid state NMR to the determination of protein secondary structure. Biochemistry 30:10382-10387.
70. Lansbury PT Jr, Costa PR, Griffiths JM, Simon EJ, Auger M, at al. 1995. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol 2:990-998.
71. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, et al. 1998. Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register, Proc Natl Acad Sci USA 95:13407-13412.
72. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, at al. 2000. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci USA 97:13045-13050.
73. Tycko R. 2006. Molecular structure of amyloid fibrils: insights from solid-state NMR. Quart Revs Biophys 1:1-55.
74. Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, et al. 2005. Correlation of structural elements and infectivity of the HET-s prion. Nature 435:844-848.
75. Siemer AB, Ritter C, Steinmetz MO, Ernst M, Riek R, et al. 2006. 13C, 15N resonance assignment of parts of the HET-s prion protein in its amyloid form. J Biomol NMR 34:75-87.
76. Wasmer C, Lange A, Van Melckebeke H, Siemer AB, Riek R, et al. 2008. Amyloid fibrils of the HET-s(218-279) prion form a beta solenoid with a triangular hydrophobic core. Science 319:1523-1526.
77. Shewmaker F, Wickner RB, Tycko R. 2006. Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure. Proc Natl Acad Sci USA 103:19754-19759.
78. Liu J-J, Sondheimer N, Lindquist S. 2002. Changes in the middle region of Sup35p profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci USA 99:16446-16453.
79. Bradley ME, Liebman SW. 2004, The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+[prions. Mol Microbiol 51:1649-1659.
80. +] prion, has a parallel in-register β-sheet structure. Proc Natl Acad Sci USA in press 105:2403-2408.
81. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, et al. 2002. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742-16747.
82. Luca S, Yau W-M, Leapman R, Tycko R. 2007. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 46:13505-13522.
83. Bruce ME. 1993. Scrapie strain variation and mutation. Br Med Bull 49: 822-838.
84. Bessen RA, Marsh RF. 1992. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol 66:2096-2101.
85. Derkatch IL, Chernoff YO, Kushnirov W, Inge-Vechtomov SG, Liebman SW. 1996. Genesis and variability of [PSI) prion factors in Saccharomyces cerevisiae. Genetics 144:1375-1386.
86. Schlumpberger M, Prusiner SB, Herskowitz I. 2001. Induction of distinct [URE3] yeast prion strains. Vol Cell Biol 21:7035-7046.
87. Bradley ME, Edskes HK, Hong JY, Wickner RB, Liebman SW. 2002. Interactions among prions and prion "strains" in yeast. Proc Natl Acad Sci USA. 99:16392-16399.
88. King CY. 2001. Supporting the structural basis of prion strains: induction and identification of [PSI] variants. J Mol Biol 307:1247-1260.
89. Toyama BH, Kelly MJ, Gross JD, Weissman JS. 2007. The structural basis of yeast prion strain variants. Nature 449:233-237.
90. Chang H-Y, Lin J-Y, Lee H-C, Wang H-L, King C-Y. 2008. Strain-specific sequences required for yeast prion [PSI+] propagation. Proc Natl Acad Sci USA in press.
91. +]. Science 268:880-884.
92. Chernoff YO. 2007. Stress and prions: lessons from the yeast model. FEBS Lett 581:3695-3701.
93. Chernoff YO, Newnam GP, Kumar J, Allen K, Zink AD. 1999. Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone Ssb in formation, stability and toxicity of the [PSI+] prion. Mol Cell Biol 19:8103-8112.
94. Jung G, Jones G, Wegrzyn RD, Masison DC. 2000. A role for cytosolic Hsp70 in yeast [PSI+] prion propagation and [PSI+] as a cellular stress. Genetics 156:559-570.
95. Kushnirov VV, Kryndushkin DS, Boguta M, Smirnov VN, Ter-Avanesyan MD. 2000. Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr Biol 10:1443-1446.
96. Kryndushkin D, Smirnov VN, Ter-Avanesyan MD, Kushnirov VV. 2002. Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions. J Biol Chem 277:23702-23708.
97. Jones G, Song Y, Chung S, Masison DC. 2004. Propagation of yeast [PSI+] prion impaired by factors that regulate Hsp70 substrate binding. Mol Cell Biol 24:3928-3937.
98. Moriyama H, Edskes HK, Wickner RB. 2000. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol Cell Biol 20:8916-8922.
99. Aron R, Higurashi T, Sahi C, Craig EA. 2007. J-protein co-chaperone Sis1 required for generation of [RNQ+] seeds for prion propagation. EMBO J 26:3794-3803.
100. Malato L, Dos Reis S, Benkemoun L, Sabate R, Saupe SJ. 2007. Role of Hsp104 in the propagation and inheritance of the [Het-s] prion. Mol Biol Cell 18:4803-4812.
101. +] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15:3127-3134.
102. Ness F, Ferreira P, Cox BS, Tuite MF. 2002. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol Cell Biol 22:5593-5605.
103. Jung G, Jones G, Masison DC. 2002. Amino acid residue 184 of yeast Hsp104 chaperone is critical for prion-curing by guanidine, prion propagation, and thermotolerance. Proc Natl Acad Sci USA 99:9936-9941.
104. Lian HY, Zhang H, Zhang ZR, Loovers HM, Jones GW, et al. 2007. Hsp40 interacts directly with the native state of the yeast prion protein Ure2 and inhibits formation of amyloid-like fibrils. J Biol Chem 282:11931-11940.
105. Bailleul PA, Newnam GP, Steenbergen JN, Chernoff YO. 1999. Genetic study of interactions between the cytoskeletal assembly protein Sla1 and prion - forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae. Genetics 153:81-94.
106. Ganusova EE, Ozolins LN, Bhagat S, Newnam GP, Wegrzyn RD, et al. 2006. Modulation of prion formation, aggregation, and toxicity by the actin cytoskeleton in yeast. Mol Cell Biol 26:617-629.
107. Allen KD, Chernova TA, Tennant EP, Wilkinson KD, Chernoff YO. 2007. Effects of ubiquitin system alterations on the formation and loss of a yeast prion. J Biol Chem 282:3004-3013.
108. Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, et al. 2003. Isolation of drugs active against mammalian prions using a yeast-based screening assay. Nat. Biotechnol 21:1075-1081.
109. Tribouillard-Tanvier D, Dos Reis S, Gug F, Voisset C, Beringue V, et al. 2008. Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs. Plos One 3:e2174.
110. Johnson SM, Wiseman RL, Sekijima Y, Green NS, Adamski-Werner SL, et al. 2005. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses. Acc Chem Res 38:911-921.
111. Allen KD, Wegrzyn RD, Chernova TA, Muller S, Newnam GP, et al. 2005. Hsp70 chaperones as modulators of prion life cycle: novel effects of Ssa and Ssb on the Saccharomyces cerevisiae prion [PSI+]. Genetics 169:1227-1242.